• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US ATTUNE FEM POR CR RT SZ 5; ATTUNE CEMENTLESS IMPLANTS : KNEE FEMORAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US ATTUNE FEM POR CR RT SZ 5; ATTUNE CEMENTLESS IMPLANTS : KNEE FEMORAL Back to Search Results
Catalog Number 150401205
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Unspecified Infection (1930)
Date of Event 10/17/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the patient underwent the surgery via tka with the implant in question.The implant in question was removed due to infection.On (b)(6) 2024, the surgeon noted that the implant in question, which had been extracted in the past, was yellowish.It was also noted that the implant in question may have been oxidized.No further information is available.Doi: on (b)(6) 2022, doe: on (b)(6) 2023.
 
Additional Manufacturer Narrative
Product complaint#: (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes, or its employees that the report constitutes an admission that the product, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.H10 additional narrative: added: d9.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Corrected: h3.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Investigation summary
=
> according to the information received, "it was reported that on an unknown date, the patient underwent the surgery via tka with the implant in question.On an unknown date, the implant in question was removed due to infection.On feb 6, 2024, the surgeon noted that the implant in question, which had been extracted in the past, was yellowish.It was also noted that the implant in question may have been oxidized.Details such as the implant (insert) used, and the date of removal surgery are unknown.A sales representative will confirm the details at a later date.No further information is available".The product was returned to depuy synthes for evaluation.The depuy synthes team conducted a visual inspection of the returned device.Visual analysis of the returned sample revealed that attune fem por cr rt sz 5 exhibits sings of what appears to be bone ingrowth and organic material on the fixation surface.However, no signs of a device non conformance were observed or defects that could have contributed to the reported event.The overall complaint was not confirmed as the observed condition of the attune fem por cr rt sz 5 would not contribute to the complained issue.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.There is no indication that a design or manufacturing issue has caused the reported complaint condition.As part of depuy synthes quality process, all devices are manufactured, inspected, and released to approved specifications.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.Device history lot
=
> a search of the depuy nonconformance (nc) quality system found no nc¿s associated with this product/lot combination.H3.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATTUNE FEM POR CR RT SZ 5
Common Device Name
ATTUNE CEMENTLESS IMPLANTS : KNEE FEMORAL
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
Manufacturer (Section G)
JTE WARSAW MFG SITE
700 orthopaedic drive
warsaw IN
Manufacturer Contact
kate karberg
700 orthopaedic dr.
warsaw, IN 46581-0988
3035526892
MDR Report Key18836001
Report Number1818910-2024-04979
Device Sequence Number20716014
Product Code MBH
UDI-Device Identifier10603295041481
UDI-Public10603295041481
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P830055
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Device Explanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number150401205
Device Lot Number9782436
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/05/2024
Supplement Date Received by Manufacturer04/01/2024
05/03/2024
Initial Report FDA Received Date03/05/2024
Supplement Report FDA Received Date04/02/2024
05/03/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/01/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ATTUNE CR RP INSRT SZ 5 5MM.; ATTUNE RP TIB BASE SZ 5 POR.
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-